Meta-Analysis of Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Area of Science:

• Urology
• Interventional Radiology
• Medical Devices

Background:

• Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
• Traditional treatments for BPH include medication and surgery.
• Prostatic artery embolization (PAE) is an emerging minimally invasive treatment option for BPH.

Purpose of the Study:

• To conduct a meta-analysis of existing data on PAE.
• To evaluate the efficacy and safety of PAE for treating BPH.

Main Methods:

• A systematic literature search was performed for studies published between November 2009 and December 2015.
• Included studies involved more than 5 patients and reported outcomes such as prostate volume, urinary flow rates, and symptom scores.
• A random-effects meta-analysis was used to assess changes in outcomes at various time points post-PAE.

Main Results:

• PAE led to significant reductions in prostate volume and postvoid residual volume at 12 months.
• Key improvements were observed in peak flow rate, International Prostate Symptom Score, and quality of life scores.
• Prostate-specific antigen and International Index of Erectile Function scores remained unchanged, indicating no adverse effects on sexual function.

Conclusions:

• PAE is an effective treatment for BPH, offering significant improvements in urinary symptoms and flow.
• The procedure is associated with a low incidence of serious adverse events (0.3%), though minor complications like rectalgia and dysuria can occur.
• PAE is a safe alternative treatment for BPH without compromising erectile function.